Glucagon-like peptide-1 receptor agonists as add-on therapy to insulin for type 1 diabetes mellitus

Glucagon-like peptide-1 receptor agonists as add-on therapy to insulin for type 1 diabetes mellitus

Background: To assess the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) used as an adjunct to insulin therapy in adults with type 1 diabetes.Methods: A search of electronic databases (Medline, Embase, and the Cochrane Central Register of Controlled Trials) from 1 Janua...

Full description

Bibliographic Details
Main Authors: Xinrui Tan, Xiongfeng Pan, Xiaochuan Wu, Songjia Zheng, Yuyao Chen, Donghai Liu, Xingxing Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Pharmacology
Subjects:
glucagon-like peptide-1 receptor agonists
meta-analysis
type 1 diabetes
adult
adjunctive therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.975880/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.975880/full

Similar Items